Today's noteworthy initiations include: Adeptus Health (ADPT) initiated with an Overweight at KeyBanc... Community Health (CYH) initiated with an Outperform at Wedbush... Dorman Products (DORM) initiated with a Buy at CL King... Dot Hill Systems (HILL) initiated with a Buy at Monness Crespi... DreamWorks (DWA) initiated with a Sell at CLSA... Fenix Parts (FENX) initiated with a Buy at BB&T... HCA Holdings (HCA) initiated with an Outperform at Wedbush... HealthSouth (HLS) initiated with a Neutral at Wedbush... Henry Schein (HSIC) initiated with an Outperform at RBC Capital... Hilltop Holdings (HTH) initiated with a Buy at Compass Point... Hutchinson Technology (HTCH) initiated with a Speculative Hold at Benchmark Co.... LifePoint (LPNT) initiated with a Neutral at Wedbush... New Mountain Finance (NMFC) initiated with a Neutral at Janney Capital... Newport (NEWP) initiated with a Buy at Benchmark Co.... Owens & Minor (OMI) initiated with a Sector Perform at RBC Capital... Raptor Pharmaceuticals (RPTP) initiated with a Buy at Citi... SCYNEXIS (SCYX) initiated with a Buy at Needham... Talen Energy (TLN) initiated with a Neutral at Macquarie... Tenet (THC) initiated with an Outperform at Wedbush... Universal Health (UHS) initiated with a Neutral at Janney Capital.

Notable companies reporting before tomorrow's open, with earnings consensus, include Exxon Mobil (XOM), consensus $2.20... Chevron (CVX), consensus $2.87... AbbVie (ABBV), consensus $2.23... HCA Healthcare (HCA), consensus $5.01... Colgate-Palmolive (CL), consensus 81c... Charter (CHTR), consensus $7.92... AutoNation (AN), consensus $4.27.

Oppenheimer lowered the firm's price target on Community Health to $4.50 from $5.50 and keeps an Outperform rating on the shares following quarterly results. The firm notes Community Health maintained its 2024 outlook. Overall, at these levels, Oppenheimer continues to see attractive upside for long-term investors.

Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSImpinj (PI) up... To see the rest of the story go to thefly.com. See Story Here

Reports Q1 revenue $3.14B, consensus $3.09B. On a same-store basis, admissions increased 3.8% and adjusted admissions increased 1.9%, compared to the same period in 2023. The company said, "We were pleased with our first quarter performance compared to both prior year and prior quarter. Progress was demonstrated on key operational and strategic priorities, and we remain focused on building further momentum as we pursue the opportunities available to us this year"

Notable companies reporting after the market close, with earnings consensus, include Meta Plataforms (META), consensus $4.32... IBM (IBM), consensus $1.60... ServiceNow (NOW), consensus $3.14... Lam Research (LRCX), consensus $7.30... Chipotle Mexican Grill (CMG), consensus $11.68... O'Reilly Automotive (ORLY), consensus $9.26... Ford Motor (F), consensus 42c... United Rentals (URI), consensus $8.32... Align Technology (ALGN), consensus $1.97... Molina Healthcare (MOH), consensus $5.59... Teradyne (TER), consensus 33c... Universa Health Services (UHS), consensus $3.16... Western Union (WU), consensus 41c.

Catheter Precision (VTAK) has received its first purchase order for LockeT from an HCA Healthcare (HCA) facility.

Augmedix (AUGX) announced the general availability of Augmedix Go for emergency departments, marking the launch of the industry's first fully-automated, generative AI powered medical documentation product for EDs across the country. The launch incorporates learnings from a pilot program with HCA Healthcare (HCA), one of the nation's leading healthcare providers. As part of the pilot, ED physicians in four HCA Healthcare hospitals utilized Augmedix Go to automate medical documentation, with the product instantaneously drafting their medical notes from patient visits. "The launch of Augmedix Go in the ED represents our unwavering commitment to develop solutions for health systems that improve their workflows. Our agility and flexible architecture, exhibited by our broad product suite and open network platform, help us address the complex and varying needs of clinicians and providers," said Manny Krakaris, CEO of Augmedix. "We have built a sophisticated platform designed to enable clinicians to be present with their patients while trusting that Augmedix technology is doing administrative work unobtrusively in the background."